Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV

By sjmartinez • January 2, 2025

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe A, Nagaddya B, Naidoo M, Hoffman RM, Lockman S; IMPAACT 2010/VESTED Study Team. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct;97(2):150-155. doi: 10.1097/qai.0000000000003473. PMID: 39742354; PMCID: PMC11684739.

Tags: Conception on antiretroviral therapy, high rates adverse outcomes, Infectious Diseases, interpregnancy interval, pregnancy outcomes, prior pregnancy loss, Publications, Women living with HIV

Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford[...]

Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature phase of the COVID-19 pandemic

Walker D, Moucheraud C, Butler D, Takayama C, Shoptaw S, Currier JS, Gladstein J, Hoffman R. Telemedicine for HIV care: a cross-sectional survey of people[...]

Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus

Li Y, Mishra NN, Chen L, Manna AC, Cheung AL, Proctor RA, Xiong YQ. Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility[...]